This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Migraine drug-specific coverage maximum lowers costs. Pharmacoecon. Outcomes News 428, 9 (2003). https://doi.org/10.1007/BF03276732
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276732